Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Background. The prognostic significance of a second programmed ventricular stimulation (PVS) at electrophysiology study (EPS), when the first PVS is negative for inducible ventricular tachycardia (VT) ...
Toward a More Clinically Useful Definition of Paroxysmal AF Recurrences seem least likely after ablation of AF in bouts lasting less than 24 hours, so maybe such very short episodes are most deserving ...
The study achieved statistically significant results of 98.7% in accurately identifying the regional arrhythmia source location for premature ventricular complex (PVC) and ventricular tachycardia (VT) ...
Please provide your email address to receive an email when new articles are posted on . In the VMAP study, a noninvasive forward-solution computational ECG mapping system met accuracy goals for ...
Members of CVRI Theme ‘Arrhythmias & Channelopathies’ are involved in various translational and clinical research projects in cardiac electrophysiology. Specific areas of interest include the genetics ...
Many arrhythmias have no clear cause; these idiopathic cases arise without identifiable triggers, while for others, the causes may be congenital or acquired.
First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results